USD 0.14
(10.5%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -226.96 Thousand | -800.67 Thousand | -1.96 Million | -541.12 Thousand | -419.03 Thousand | -533.1 Thousand |
Net Income | -612 Thousand | -1.97 Million | -2.32 Million | -4.07 Million | -547.75 Thousand | -593.73 Thousand |
Depreciation & Amortization | 7217.00 | 5963.00 | 4239.00 | - | - | 943.00 |
Deferred income taxes | - | 209.92 Thousand | 1349.00 | - | - | - |
Stock-based compensation | - | 199.43 Thousand | 179.17 Thousand | 260.32 Thousand | - | 133.2 Thousand |
Change in working capital | 257.85 Thousand | 732.37 Thousand | 127.79 Thousand | 281.06 Thousand | 126.81 Thousand | -72.87 Thousand |
Other non-cash items | 90.4 Thousand | 24.66 Thousand | 42.49 Thousand | 2.98 Million | 1909.00 | -644.00 |
Investing Cash Flow | - | -6255.00 | -269.11 Thousand | 50.64 Thousand | -22.32 Thousand | - |
Investments in PPE | - | -6255.00 | -19.11 Thousand | - | - | - |
Acquisitions | - | - | - | 27.37 Thousand | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -250 Thousand | 23.27 Thousand | -22.32 Thousand | - |
Financing Cash Flow | - | 999.8 Thousand | 1.83 Million | 869.91 Thousand | 54.69 Thousand | 986.37 Thousand |
Debt repayment | - | - | -250 Thousand | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 1 Million | -2500.00 | 319.91 Thousand | 54.69 Thousand | 1 Million |
Other Financing Activities | - | -200.00 | 2.08 Million | 550 Thousand | 54.69 | -13.63 Thousand |
Accounts receivables | 43.99 Thousand | -69.87 Thousand | -15.08 Thousand | -481.00 | 25.9 Thousand | -32.67 Thousand |
Accounts payables | - | - | - | - | 94.85 Thousand | -31.18 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | 213.86 Thousand | 802.24 Thousand | 142.87 Thousand | 281.54 Thousand | 6058.00 | -9005.00 |
Cash at beginning of period | 237.43 Thousand | 44.56 Thousand | 447.51 Thousand | 68.06 Thousand | 454.73 Thousand | 1469.00 |
Cash at end of period | 10.47 Thousand | 237.43 Thousand | 44.56 Thousand | 447.51 Thousand | 68.06 Thousand | 454.73 Thousand |
Capital Expenditure | - | -6255.00 | -19.11 Thousand | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -226.96 Thousand | 192.87 Thousand | -402.94 Thousand | 379.44 Thousand | -386.66 Thousand | 453.26 Thousand |
Free Cash Flow | -226.96 Thousand | -806.93 Thousand | -1.98 Million | -541.12 Thousand | -419.03 Thousand | -533.1 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -151.42 Thousand | -72.79 Thousand | -185.6 Thousand | -612 Thousand | -105.76 Thousand | -143.45 Thousand |
Depreciation & Amortization | 931.00 | 1804.00 | 1804.00 | 7217.00 | 1805.00 | 1804.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 85.04 Thousand | 70.35 Thousand | 88.8 Thousand | 257.85 Thousand | 103.15 Thousand | 17.97 Thousand |
Other non-cash items | 25.65 Thousand | 10.63 Thousand | 91.56 Thousand | 90.4 Thousand | 7561.00 | 7480.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 47 Thousand | - | - | - | - | - |
Debt repayment | -47 Thousand | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 47 Thousand | - | - | - | - | - |
Accounts receivables | -14.71 Thousand | 452.00 | -1246.00 | 43.99 Thousand | 8560.00 | -14.24 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 99.75 Thousand | 69.9 Thousand | 90.05 Thousand | 213.86 Thousand | 94.59 Thousand | 32.21 Thousand |
Cash at beginning of period | 17.31 Thousand | 10.47 Thousand | 18.75 Thousand | 237.43 Thousand | 11.99 Thousand | 128.19 Thousand |
Cash at end of period | 7940.00 | 17.31 Thousand | 10.47 Thousand | 10.47 Thousand | 18.75 Thousand | 11.99 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -9374.00 | 6838.00 | -8280.00 | -226.96 Thousand | 6759.00 | -116.2 Thousand |
Free Cash Flow | -56.37 Thousand | 6838.00 | -8280.00 | -226.96 Thousand | 6759.00 | -116.2 Thousand |
ANKOF
CTP2
MLD-M
SOLB
SMSPHARMA
002255